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Abstract
Background: Chinese herbal medicine is increasingly widely used as a complementary approach for control of
breast cancer recurrence and metastasis. In this paper, we examined the implicit prescription patterns behind the
Chinese medicinal formulae, so as to explore the Chinese medicinal compatibility patterns or rules in the treatment
or control of breast cancer recurrence and metastasis.
Methods: This study was based on the herbs recorded in Pharmacopoeia of the People’s Republic of China, and
the literature sources from Chinese Journal Net and China Master Dissertations Full-text Database (1990 – 2010) to
analyze the compatibility rule of the prescription. Each Chinese herb was listed according to the selected medicinal
formulae and the added information was organized to establish a database. The frequency and the association
rules of the prescription patterns were analyzed using the SPSS Clenmentine Data Mining System. An initial
statistical analysis was carried out to categorize the herbs according to their medicinal types and dosage, natures,
flavors, channel tropism, and functions. Based on the categorization, the frequencies of occurrence were computed.
Results: The main prescriptive features from the selected formulae of the mining data are: (1) warm or cold herbs
in the Five Properties category; sweet or bitter herbs in the Five Flavors category and with affinity to the liver
meridian are the most frequently prescribed in the 96 medicinal formulae; (2) herbs with tonifying and
replenishing, blood-activating and stasis-resolving, spleen-strengthening and dampness-resolving or heat-clearing
and detoxicating functions that are frequently prescribed; (3) herbs with blood-tonifying, yin-tonifying, spleen-
strengthening and dampness-resolving, heat-clearing and detoxicating, and blood-activating with stasis-resolving
functions that are interrelated and prescribed in combination with qi-tonifying herbs.
Conclusions: The results indicate that there is a close relationship between recurrence and metastasis of breast
cancer with liver dysfunctions. These prescriptions focus on the herbs for nourishing the yin-blood, and emolliating
and regulating the liver which seems to be the key element in the treatment process. Meanwhile, the use of qi-
tonifying and spleen-strengthening herbs also forms the basis of prescription patterns.
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Background
Breast cancer is one of the most common malignant
tumors among women, and the incidence increases every
year in both developed and developing countries [1]. Every
year, among the 1.2 million women diagnosed with breast
cancer worldwide, 500 thousand cases die of the disease.
Along with a sharp increase in life expectancy, expansion
of urbanization and adaptation of western lifestyle, the
increase in incidence rates is even more obvious in devel-
oping countries [2-5]. In China, the number of cases
increased by 38.5% from 2000 to 2005. Compared with the
early surveys in the 1990s, breast cancer accounted for the
largest increase in mortality rates in 2005 [6].
Today, the standard therapies for breast cancer include
surgery, chemotherapy, radiation therapy, and hormonal
therapy. However, even though patients receive systemic
treatment, there is still 10% to 30% chance of recurrence
and metastasis. Among the patients with local recurrence,
75% to 93% will eventually develop distant metastasis with
an extremely low 5-year survival rate [7,8]. Visceral metas-
tasis is the main reason for treatment failure and cause of
death. Lung, bone, liver and brain are the most common
sites of distant spread of breast cancer [9,10]. Since metas-
tasis is the main reason for cancer treatment failure, man-
agement of metastasis is the key factor for determining the
prognosis of the patients [11].
Recently, the use of natural Chinese herbal medicine
with anti-tumor effects is receiving more and more atten-
tion from the public [12]. In traditional Chinese medicine
(TCM), the treatment and prevention of breast cancer
recurrence and metastasis is a holistic approach through
multi-level, multi-target and multi-channel control. CTM
differs from Western medicine, which adopts ways to
block a single transfer in a particular process. In compari-
son, Chinese medicine adopts an overall therapeutic
approach to treat and prevent recurrence and metastasis,
to improve the immune system of patients, and to
strengthen the body’s susceptibility to diseases. Mean-
while, Chinese medicine also aims at reducing the side
effects of radiotherapy and chemotherapy, reversing drug
resistance and improving quality of life and survival for
patients. Therefore, these unique advantages have gradu-
ally made the Chinese medicinal approach in combating
breast cancer recurrence and metastasis the research focus
of both the local and overseas scholars [13,14].
In Chinese medicinal therapy, experienced Chinese
medical practitioners prescribe a medicinal formula—a
combination of various single herbs—for the treatment of
ailments. According to TCM theories, pharmacological
and pharmacodynamic relationship exists among herbs,
which is deemed as Chinese medicinal compatibility. The
compatibility of Chinese herbal medicine has particular
rules and patterns. In Chinese medicinal database, there
are over ten thousand medicinal formulae which enclose
complicated information. However, a well-established and
orderly system for organizing the information of Chinese
medicinal formulae does not exist. This implies that a
large amount of implicit prescription patterns behind the
formulae have not been fully disclosed [15,16].
Association rules mining is one of the methods for
discovering meaningful associations or correlations
between variables in large databases. It identifies fre-
quent item sets from the data sets, and then uses these
frequent item sets to form their association rules. To
select meaningful rules from the set of all possible rules,
minimum thresholds on support and confidence are the
two important constraints. An association rule has the
form LHS⇒RHS, where LHS and RHS are sets of items,
and the RHS set is likely to occur whenever the LHS set
occurs. One of the applications of association rules
mining is to mine association rules in medical record
data [17,18]. Since association rules mining is a popular
and well-researched method, it can be used to investi-
gate the Chinese herbal medicine compatibility patterns,
and to reflect the interdependence and relationship
between the variables. Therefore, it can provide scienti-
fic evidence for clinical applications of Chinese medi-
cine, and thereby offer an implication for the integration
of Chinese medicinal therapy with modern Western
medical therapies to better treatment or prevention of
breast cancer recurrence and metastasis [19]. The sup-
port supp(X) of an item set X is defined as the propor-
tion of transactions in the data set containing the item
set. It is a function used for evaluation of the potential
usefulness of the rules. The confidence of a rule is
defined as conf(X => Y), which can be interpreted as an
estimate of the probability P (Y|X) [20].
Methods
Sources of literature
This study was based on Pharmacopoeia of the People’s
Republic of China[21] recorded to investigate the prescrip-
tion patterns of using Chinese medicine for treatment and
prevention of breast cancer recurrence and metastasis. The
sources of literature included the Chinese Journal Net and
the China Master Dissertations Full-text Database (1990 –
2010) (Table 1). The name of each herb was used as a key-
word to obtain the relevant literature, and only the litera-
ture which focused on “breast cancer”, “advanced stage of
breast cancer” and/or “post-operation of breast cancer” was
eligible for inclusion. According to the following inclusion
and exclusion criteria, a total of 131 papers describing var-
ious medicinal formulae for clinical applications were
included (96 medicinal formulae with a total of 180 Chinese
herbal medicines (herbs); the total cumulative occurrences
of 180 herbs appearing in 96 formulae were 1001 times).
The terminologies used in this article refer to ‘WHO Inter-
national Standard Terminologies on Traditional Medicine
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in the Western Pacific Region’, which has documented the
common technical terms used in traditional medicine.
Inclusion criteria
There were five types of literature included, including
literature: (1) related to clinical research on using Chi-
nese medicine for the prevention and treatment of
breast cancer recurrence and metastasis; (2) related to
clinical research on using Chinese medicine for the
treatment of advanced stage breast cancer; (3) related to
clinical research on using Chinese medicine for the pre-
vention of postoperative breast cancer recurrence and
metastasis (especially at stage III or later when metasta-
sis had occurred); (4) with randomized controlled trials
as the study design; and (5) where the clinical study
aims to prove the efficacy of experimental group with
Chinese medicinal treatment over control group.
Exclusion criteria
Literature with the following criteria were excluded: (1)
small-sample-sized studies with less than 20 cases; (2)
studies which primarily aimed to treat complications of
operations or to reduce the side effects of chemother-
apy; (3) studies without investigation into the use of
Chinese medicine for the treatment and prevention of
breast cancer recurrence and metastasis; (4) studies
which provided only the names of formulae but without
descriptions of herbal ingredients; (5) duplicate publica-
tions reporting the same group of participants; and (6)
literature in which the clinical trial received a Jadad
score of less than 2.
Statistical analysis
Association rules mining is a popular and well-
researched method for discovering interesting relations
between variables in large databases [22]. We used the
following definition for item sets and association rules.
An association rule has the form LHS⇒RHS, where LHS
and RHS are sets of items and the RHS set is likely to
occur whenever the LHS set occurs [23].
Two parameters (support factor and confidence factors)
were essential in association rules mining. With regard to
support and confidence in discovering the association
rules, the user shall set the minimum support (min-sup)
and the minimum confidence (min-conf) as critical values
providing the baselines for discovery. Only the combina-
tions that satisfy the minimum thresholds on support and
confidence were considered to mine meaningful rules. The
selection of thresholds (support and confidence) was
always an issue. If the minimum confidence is set too
high, a lot of useful data will be missed. To find an effec-
tive drug compatibility mode, we discovered central ten-
dency of association rules to be more obvious at the
support of 0.1 and confidence of 0.6 in the two correlation
analysis of these herbs (used pairs of couplet herbs) and
the pairs of herbal functions. So the minimum support of
0.1 and the minimum confidence of 0.6 were specified in
this study.
Based on Pharmacopoeia of the People’s Republic of
China, the ingredients of Chinese medicine were listed
according to the selected medicinal formulae and were
organized to establish a database. The computing soft-
ware Microsoft ACCESS was used as a storage tool, and
then the SPSS Clenmentine Data Mining System was
used as a platform to analyze the frequency and the asso-
ciation rules of the prescription patterns. An initial statis-
tical analysis of the database was carried out to
categorize the herbs according to their medicinal types
and dosage, natures, flavors, channel tropism, and func-
tions. The frequencies of occurrence and use were then
computed based on the categorization. In additionthe
associations between different functions of Chinese herbs
from the formulae were also examined using the associa-
tion rules mining.
Table 1 Data source of the literature (1990-2010)
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Pharmacopoeia of the People’s Republic of China
(2005 Edition) Volume I
“breast cancer” and/or “advanced stage” and/or “post-
operation”"clinical research “ “TCM”, “prevention and treatment
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Pharmacopoeia of the People’s Republic of China
(2005 Edition) Volume I
“breast cancer” and/or “advanced stage” and/or “post-
operation” “clinical research “ “TCM”, “prevention and
treatment of breast cancer recurrence and metastasis” and be





The herbs recorded in Chinese Materia Medica and
Pharmacopoeia of the People’s Republic of China
(2005 Edition) Volume I
“breast cancer” and/or “advanced stage” and/or “post-
operation” “clinical research “ “TCM”, “prevention and
treatment of breast cancer recurrence and metastasis” and be
eligible for selection criteria
2
Among the 131 papers searched from the databases, 96 medicinal formulae were included in the study according to the inclusion and exclusion criteria
* According to the inclusion and exclusion criteria, a total of 131 papers which described various Chinese medicinal formulae for clinical applications were
included 96 medicinal formulae with a total of 180 herbs. Total cumulative occurrences of 180 herbs appearing in 96 formulae is 1001 times.
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Results
Associations between Five Properties and Five Flavors
from 180 herbs prescribed in 96 formulae
The 180 herbs were categorized according to the Five
Properties and Five Flavors (Table 2 & Table 3). Based
on the Five properties and Five flavors theory of
TCM, herbs with a warm (67 herbs, 37.22%) or cold
(60 herbs, 33.33%) nature were most frequently pre-
scribed in terms of the occurrence frequency, while
herbs with a warm (appeared 90 times, 93.75%), cold
(appeared 71 times, 73.96%) and neutral (appeared 82
times, 85.42%) nature were the top three prescribed
herbs in terms of the frequency of use. According to
the Five Flavors (Table 3), herbs that were sweet (94
herbs, appeared 93 times, 96.88%) or bitter (87 herbs,
appeared 86 times, 89.58%) were the top two pre-
scribed herbs in terms of both the frequencies of
occurrence and use.
Association between Channel tropism theory from 180
herbs prescribed in 96 formulae
The results of the association analysis based on channel
tropism theory among 180 herbs (Table 4) showed that
the top two most frequently prescribed herbs have high
affinity to the liver and spleen. The herbs that have high
affinity to the liver channel were used most frequently
(frequency of use = 44.79%).
Frequency distribution of a single herb prescribed in
Chinese medicinal formulae
There are 96 medicinal formulae with a total of 180
herbs included in this study. The total cumulative
occurrence of 180 herbs appearing in 96 formulae was
1001 times. The following 13 herbs were frequently pre-
scribed (over 20 times):
a Principal function in qi-tonifying, including : Huang
Qi (Radix Astragali), Bai Zhu (Rhizoma Atractylodis
Macrocephalae), Gan Cao (Radix Glycyrrhizae Uralen-
sis), Tai Zi Shen (Radix Pseudostellariae), Dang Shen
(Radix Codonopsitis Pilosulae)
b Principal function in spleen-fortifying and dampness-
resolving, including : Fu Ling (Sclerotium Poriae Cocos),
Yi Yi Ren (Semen Coicis),
c Principal function in heat-clearing and detoxicating,
including : Shan Ci Gu (Pseudobulbus Shancigu), Bai
Hua She She Cao (Herba Hedyotidis Diffusae),
d Principal function in blood-tonifying, including:
Dang Gui (Radix Angelicae Sinensis), u
e Principal function in yin-tonifying, including: Gou Qi
Zi (Fructus Lycii),
f Principal function in blood-activating and stasis-
resolving, including: E Zhu (Rhizoma Curcuma Phaeo-
caulis), and
g Principal function in qi-regulating, including: Chen
Pi (Pericarpium Citri Reticulatae) (Table 5).
Frequency distribution of categorized herbs according to
their functions
Herbs with tonifying and replenishing (qi-tonifying,
blood-tonifying, yin-tonifying and yang-tonifying),
blood-activating and stasis-resolving, spleen-fortifying
and dampness-resolving or heat-clearing and detoxicat-
ing functions appeared to be most frequently prescribed
for the treatment and prevention of breast cancer recur-
rence and metastasis (Table 6). The top three functions
included herbs with qi-tonifying, heat clearing and
detoxicating, and blooad-activiating and stasis-resolving
functions.
Associations between pairs of herbs functions from the
formulae
Association rules mining was applied to investigate the
associations between pairs of herb functions from the
formulae, and to examine the Chinese medicinal com-
patibility patterns (Table 7). The minimum support of
0.1 and the minimum confidence of 0.6 were specified.
The top three pairs of herbal functions with the high-
est confidence included the blood-tonifying paired with
qi-tonifying functions (93.18%), the qi-regulating paired
with qi-tonifying functions (93.10%) and the yin-tonify-
ing paired with qi-tonifying functions (92.50%).
Associations between pairs of couplet herbs from the
formulae
Couplet herbs are two herbs used in pair to increase
the therapeutic effect or reduce the toxic effect. To
Table 2 Association of the herbs from 96 formulae with Five Properties (N = 180 in 96 formulae)
Five properties Number of herbs Occurrence frequency (%) Number of formulae Frequency of use (%)
Warm 67 37.22 90 93.75
Cold 60 33.33 71 73.96
Neutral 40 22.22 82 85.42
Cool 8 4.44 44 45.83
Hot 5 2.78 8 8.33
Occurrence frequency = number of herbs belonging to each category / total number of recorded herbs (i.e. 180); Frequency of use = number of formulae
recording the use of the herbs / total number of selected formulae (i.e.: 96).
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Table 3 Association of the herbs from 96 formulae with Five Flavors (N = 180 in 96 formulae)
Five flavors Number of herbs Occurrence frequency (%) Number of formulae Frequency of use (%)
Sweet 94 52.22 93 96.88
Bitter 87 48.33 86 89.58
Pungent 64 35.56 80 83.33
Salty 21 11.67 37 38.54
Sour 18 10 40 41.67
Occurrence frequency = number of herbs belonging to each category / total number of recorded herbs (i.e. 180); Frequency of use = number of formulae
recording the use of the herbs / total number of selected formulae (i.e.: 96)
Table 4 Association of the herbs from 96 formulae with Channel tropism (N = 180 in 96 formulae)
Channel Tropism Number of herbs Occurrence frequency (%) Number of formulae Frequency of use (%)
Liver (Gall bladder) 120(13) 27.09 43(9) 44.79
Spleen (Stomach ) 126(59) 28.44 42(35) 43.75
Lung (Large intestine) 77(14) 17.38 36(13) 37.50
Kidney (Urinary bladder) 64(12) 14.45 28(9) 29.17
Heart (Small intestine) 51(4) 11.51 26(4) 27.08
Triple energizers (Pericardium) 3(2) 1.13 3(2) 3.13
Occurrence frequency = number of herbs belonging to each category / total number of recorded herbs (i.e.: 180); Frequency of use = number of formulae
recording the use of the herbs / total number of selected formulae (i.e.: 96).
Table 5 The top 13 herbs being used among the 180 herbs of the formulae in frequency
No. Herbs (Pharmaceutical name) Number of occurrences Frequency of use (%)
1 Huang Qia (Radix Astragali) 60 62.50
2 Bai Zhua (Rhizoma Atractylodis Macrocephalae) 45 46.88
3 Fu Lingb (Sclerotium Poriae Cocos) 39 40.63
4 Shan Ci Guc (Pseudobulbus Shancigu) 27 28.13
5 Dang Guid (Radix Angelicae Sinensis) 26 27.08
6 Yi Yi Renb (Semen Coicis) 25 26.04
7 Bai Hua She She Caoc (Herba Hedyotidis Diffusae) 25 26.04
8 Gan Caoa (Radix Glycyrrhizae Uralensis) 23 23.96
9 Tai Zi Shena (Radix Pseudostellariae) 22 22.92
10 Gou Qi Zie (Fructus Lycii) 22 22.92
11 Dang Shena (Radix Codonopsitis Pilosulae) 21 21.88
12 E Zhuf (Rhizoma Curcuma Phaeocaulis) 20 20.83
13 Chen Pig (Pericarpium Citri Reticulatae) 20 20.83
Frequency of use = number of formulae recording the use of the herbs / total number of selected formulae
Table 6 The top 10 kinds of function herb among the 180 herbs of the formulae in frequency








1 Qi-tonifying 213 21.28 79 82.29
2 Heat-clearing and
detoxicating
113 11.29 53 55.21
3 Blood-activating and stasis-
resolving
104 10.39 56 58.33
4 Yang-tonifying 79 7.89 36 37.5
5 Spleen-fortifying and
dampness-resolving
77 7.69 51 53.13
6 Yin-tonifying 70 6.99 40 41.67
7 Blood-tonifying 67 6.69 44 45.83
8 Phlegm-resolving 50 05. 37 38.54
9 Qi-regulating 48 4.8 29 30.21
10 Liver-soothing 21 2.1 19 19.79
Occurrence frequency = number of occurrences for the herbs appearing in various formulae / total cumulative occurrences for 180herbs appearing in 96
formulae ( i.e.: 1001); Frequency of use = number of formulae recording the use of the herbs / total number of selected formulae.
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further examine the compatibility patterns of couplet-
medicinal prescriptions, we targeted the herbs for
healthy-qi reinforcement (including qi-tonifying, yin-
tonifying, blood-tonifying, yang-tonifying and spleen-
fortifying and dampness-resolving), and the herbs for
pathogenic-factor elimination (including heat-clearing
and detoxicating, blood-activating and stasis-resolving,
and qi-regulating), which were frequently prescribed
for the treatment and prevention of breast cancer
recurrence and metastasis (Table 8). The minimum
support of 0.1 and the minimum confidence of 0.6
were specified. The top three pairs of couplet herbs
with the highest confidence included the Tai Zi Shen
paired with Bai Zhu (86.36%), the Bai Zhu paired with
Huang Qi (84.44%), and the Bai Zhu paired with Fu
ling (77.78%).
Discussion
From the herbal perspective, breast cancer is the local
manifestation of a whole-body disease, referred to as an
intrinsically deficient but extrinsically excessive syn-
drome. Based on TCM theories, deficiency of spleen qi,
inadequate source of engendering transformation, defi-
ciency of qi and blood, and excess of phlegm-dampness
are believed to be the main mechanism responsible for
development of breast cancer [24,25].
Medicinal formulae often include herbs that are sweet or
bitter
The 180 herbs were classified according to the Five Fla-
vors, and herbs that were sweet or bitter were the top
two most frequently prescribed herbs in the formulae. In
TCM theories, herbs that taste sweet can be used for
supplementation, moderation and harmonization,
referred to as tonifying and replenishing herbs. Herbs
that taste bitter can be used for discharging and down-
bearing, referred to as heat-clearing and detoxicating
herbs. However, sweet tasting herbs with spleen-
strengthening functions were prescribed and used more
frequently than herbs with a bitter taste for clearing heat.
There is a close relationship between recurrence and
metastasis of breast cancer and liver, and herbs for
nourishing the yin-blood, emolliating and soothing the
liver, and smoothing the meridians are the keys of breast
cancer treatment
Breast cancer is different from the other cancer types, as
the onset of this disease usually peaks at menopausal
Table 7 The pairs of herbal functions being used among the formulae
Herb functions (LHS, X) Number of
formulae






Blood-tonifying 44 ® Qi-tonifying 41 42.71 93.18
Yin-tonifying 40 ® Qi-tonifying 37 38.54 92.50
Phlegm-resolving 37 ® Qi-tonifying 34 35.42 91.89
Spleen-fortifying and dampness-
resolving
51 ® Qi-tonifying 46 47.92 90.20
Qi-regulating 29 ® Qi-tonifying 27 28.13 93.10
Yang-tonifying 36 ® Qi-tonifying 32 33.33 88.89
Heat-clearing and detoxicating 53 ® Qi-tonifying 46 47.92 86.79
Blood-activating and stasis-
resolving
56 ® Qi-tonifying 47 48.96 83.93
Blood-activating and stasis-
resolving
56 ® Heat-clearing and detoxicating 35 36.46 62.50
Heat-clearing and detoxicating 53 ® Spleen-fortifying and dampness-
resolving
32 33.33 60.38
Blood-tonifying 44 ® Yin-tonifying 27 28.13 61.36
Table 8 The commonly used pairs of couplet herbs in the formulae
Herbs (LHS, X) Number of formulae Herb (RHS, Y) Number of formulae Support (X) (%) Confidence (X => Y) (%)
Tai Zi Shen 22 ® Bai Zhu 19 19.79 86.36
Bai Zhu 45 ® Huang Qi 38 39.58 84.44
Bai Zhu 45 ® Fu Ling 35 36.46 77.78
Bai Hua She She Cao 25 ® Fu Ling 19 19.79 76.00
Bai Hua She She Cao 25 ® Yi Yi Ren 17 17.71 68.00
Yi Yi Ren 25 ® Fu Ling 17 17.71 68.00
E Zhu 20 ® Shan Ci Gu 12 12.50 60.00
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[26]. The pathological characteristic of this period is
marked by exhaustion of heavenly tenth. During this
period, the body suffers from yin-blood deficiency, and
liver-kidney depletion. Liver is the organ for storing
blood. Liver functions in free coursing, and its functions
are based on sufficiency of yin-blood. In other words,
the free coursing relies on the sufficiency of yin-blood
stored in the liver. Therefore, not only herbs for sooth-
ing the liver and regulating qi are needed, but also the
herbs for emolliating the liver blood are essential for the
treatment and prevention of breast cancer recurrence
and metastasis. From the association rule mining, the
herbs, such as Shao Yao, Wu Wei Zi, Ji Xue Teng,
Sheng Shu Di, Gou Qi Zi, Nu Zhen Zi, and Dang Gui,
are used directly for blood-tonifying and liver-emolliat-
ing in treatment of breast cancer. In general, herbs for
nourishing the yin-blood, emolliating the liver, soothing
the liver and smoothing the meridians play a key role in
breast cancer treatment.
Ample clinical research of Chinese formulae reinforces
the spleen to regulate qi and soothe the liver to alleviate
pain. Thus, they do not only resist tumor and
strengthen the body, but also have anti-cancer effects on
metastatic breast cancer [27,28].
The use of herbs for reinforcement of healthy qi and
elimination of pathogenic factors is a common Chinese
medicinal combination
From the TCM perspective, the etiology of breast cancer
is due to deficiency of the healthy qi, which is related to
spleen qi deficiency, and liver-kidney depletion. This
deficiency will result in malfunctioning of spleen, liver
and kidney for transportation and transformation, and
free coursing. Without the proper functioning, stagna-
tion and obstruction of the breast collaterals will ulti-
mately be developed and transformed into breast cancer
[29].
The use of qi-tonifying and spleen-fortifying herbs is the
basis of prescription patterns for preventing breast
cancer recurrence and metastasis
Restoration of healthy qi is an effective way to treat dis-
eases and to prevent further progression. The use of qi-
tonifying and spleen-fortifying herbs is to replenish the
source of engendering transformation for qi and blood,
and to achieve qi-tonifying, blood-replenishing and har-
mony of the five visceral functions. This is particularly
essential for nourishing the liver and smoothing the qi
movement. At the same time, spleen-strengthening and
qi-replenishing herbs also have the functions for resol-
ving dampness and dispelling phlegm. Therefore, the
formulae prescribed herbs such as Huang Qi, Bai Zhu,
and Fu Ling, among others.. From the association rules
mining, the results showed that the combination of the
herbs should also focus on the functions for qi-tonifying.
The use of couplet herbs involving Huang Qi and Bai
Zhu is to achieve the effects of spleen-strengthening and
qi-replenishing, and dampness-drying and water-drain-
ing; the use of couplet herbs involving Bai Zhu and Tai
Zi Shen is to achieve the effects of fluid-engendering
and lung-moistening; the use of couplet herbs involving
Bai Zhu and Fu Ling is to achieve the effects of damp-
ness-resolving. The effectiveness of these tonifying and
replenishing herbs on tumor resistance and immunity
enhancement has also been proven by clinical studies
[30,31].
Conclusions
The results showed that recurrence and metastasis of
breast cancer is considered to have a close relationship
with liver dysfunctions. These prescriptions focus on the
herbs for nourishing the yin-blood, and emolliating and
regulating the liver. Strengthening of liver function
seems to be the key to successful treatment. Meanwhile,
the use of qi-tonifying and spleen-strengthening herbs
also forms the basis of prescription patterns. It is also
noteworthy that liver function is promoted by strength-
ening the spleen.
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